4.4 Review

A systematic review of diabetic retinopathy screening intervals

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Ophthalmology

Five-Year Incidence of Proliferative Diabetic Retinopathy and Associated Risk Factors in a Nationwide Cohort of 201 945 Danish Patients with Diabetes

Sebastian Dinesen et al.

Summary: This study evaluated the progression rates of proliferative diabetic retinopathy (PDR) and identified the demographic and clinical characteristics of patients who developed PDR. The results showed that within 5 years, 2384 eyes of 1780 patients progressed to PDR. Factors associated with PDR development included longer duration of diabetes, type 1 diabetes, systemic comorbidity, use of insulin, and antihypertensive medications.

OPHTHALMOLOGY SCIENCE (2023)

Article Ophthalmology

Validation of a model for the prediction of retinopathy in persons with type 1 diabetes

Vivian Schreur et al.

Summary: This study validated a model for predicting diabetic retinopathy in persons with type 1 diabetes, demonstrating that a personalised screening program could reduce screening frequency and had good discriminatory ability.

BRITISH JOURNAL OF OPHTHALMOLOGY (2021)

Article Ophthalmology

Ten-year incidence and assessment of safe screening intervals for diabetic retinopathy: the OPHDIAT study

Chloe Chamard et al.

Summary: The study estimated the 10-year incidence of referable diabetic retinopathy in a French population with type 1 and 2 diabetes mellitus, and assessed safe screening intervals for patients without retinopathy. Results showed that the safe screening intervals for type 1 and 2 diabetes were 2.2 years and 3.0 years, respectively, for patients without retinopathy at the first examination.

BRITISH JOURNAL OF OPHTHALMOLOGY (2021)

Editorial Material Endocrinology & Metabolism

Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy

Kuan-Yu Lin et al.

Summary: Despite advancements in treating diabetic macular edema and retinopathy, limited medical resources contribute to lower fundus examination rates, delaying diagnosis and treatment. Implementation of automated screening programs and identification of specific biomarkers are crucial for early detection, reducing the prevalence of poor vision and blindness.

JOURNAL OF DIABETES INVESTIGATION (2021)

Article Medicine, General & Internal

Four-Year Screening Interval and Vision-Threatening Retinopathy in Type 2 Diabetes Patients With Good Glycemic Control

Tetsuro Tsujimoto et al.

Summary: The study found that patients with type 2 diabetes who had good glycemic control during follow-up had a lower incidence of vision-threatening retinopathy; for patients with mild to moderate nonproliferative diabetic retinopathy, poor glycemic control significantly increased the incidence of vision-threatening retinopathy; patients with longer durations of diabetes had lower rates of remission of diabetic retinopathy.

MAYO CLINIC PROCEEDINGS (2021)

Review Ophthalmology

Recently updated global diabetic retinopathy screening guidelines: commonalities, differences, and future possibilities

Taraprasad Das et al.

Summary: The study revealed similarities and variations between country-specific diabetic retinopathy (DR) screening guidelines, with differences mainly in screening location and referral timelines. Digital fundus photography has largely replaced traditional methods, with increasing interest in non-mydriatic fundus cameras.
Review Ophthalmology

Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045 Systematic Review and Meta-analysis

Zhen Ling Teo et al.

Summary: The translated paragraphs provide updated estimates on the global prevalence and number of people with diabetic retinopathy (DR) through 2045. The burden of DR is expected to increase disproportionately in countries in the Middle East and North Africa and the Western Pacific by 2045. Certain ethnic groups such as Hispanics and Middle Easterners with diabetes are more likely to have DR compared to Asians.

OPHTHALMOLOGY (2021)

Article Ophthalmology

Diabetic retinopathy screening guidelines in India: All India Ophthalmological Society diabetic retinopathy task force and Vitreoretinal Society of India Consensus Statement

Rajiv Raman et al.

Summary: This article is a consensus statement of AIOS DR task force and VRSI on practical guidelines of DR screening in India, emphasizing the importance of screening and the measures that should be taken.

INDIAN JOURNAL OF OPHTHALMOLOGY (2021)

Article Endocrinology & Metabolism

Screening for Diabetic Retinopathy with Extended Intervals, Safe and Without Compromising Adherence: A Retrospective Cohort Study

Ali Sharif et al.

Summary: Extending screening intervals for diabetic retinopathy can result in high adherence rates to screening programs without compromising patient safety. However, extra attention may be needed for younger subjects and those at higher risk of progression.

DIABETES THERAPY (2021)

Article Ophthalmology

Diabetic Retinopathy Preferred Practice Pattern®

Timothy W. Olsen et al.

OPHTHALMOLOGY (2020)

Review Endocrinology & Metabolism

Global trends in diabetes complications: a review of current evidence

Jessica L. Harding et al.

DIABETOLOGIA (2019)

Article Ophthalmology

Evidence-based Danish guidelines for screening of diabetic retinopathy

Jakob Grauslund et al.

ACTA OPHTHALMOLOGICA (2018)

Article Public, Environmental & Occupational Health

Determining diabetic retinopathy screening interval based on time from no retinopathy to laser therapy

Daniel Hughes et al.

JOURNAL OF MEDICAL SCREENING (2017)

Article Endocrinology & Metabolism

A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy

Stela Vujosevic et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)

Article Ophthalmology

Availability and variability in guidelines on diabetic retinopathy screening in Asian countries

Louis Zizhao Wang et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2017)

Review Ophthalmology

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review

Sian Taylor-Phillips et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2016)

Article Health Care Sciences & Services

Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening

Peter H. Scanlon et al.

HEALTH TECHNOLOGY ASSESSMENT (2015)

Article Endocrinology & Metabolism

External validation of a risk assessment model to adjust the frequency of eye-screening visits in patients with diabetes mellitus

Enrique Soto-Pedre et al.

JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)

Article Nursing

The Systematic Review

Edoardo Aromataris et al.

AMERICAN JOURNAL OF NURSING (2014)

Article Nursing

Study Selection and Critical Appraisal

Kylie Porritt et al.

AMERICAN JOURNAL OF NURSING (2014)

Article Nursing

Developing the Review Question and Inclusion Criteria

Cindy Stern et al.

AMERICAN JOURNAL OF NURSING (2014)

Article Nursing

Constructing a Search Strategy and Searching for Evidence

Edoardo Aromataris et al.

AMERICAN JOURNAL OF NURSING (2014)

Article Ophthalmology

Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe: 1990-2010

Rupert R. A. Bourne et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2014)

Article Endocrinology & Metabolism

Validation of a model to estimate personalised screening frequency to monitor diabetic retinopathy

Amber A. W. A. van der Heijden et al.

DIABETOLOGIA (2014)

Review Endocrinology & Metabolism

Screening intervals for diabetic retinopathy and incidence of visual loss: a systematic review

J. B. Echouffo-Tcheugui et al.

DIABETIC MEDICINE (2013)

Article Ophthalmology

Biennial eye screening in patients with diabetes without retinopathy:: 10-year experience

E. Olafsdottir et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2007)

Article Medicine, General & Internal

Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus

S Vijan et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)